Bio‑Rad has launched a portfolio of Vericheck ddPCR™ Kits compatible with the QX700™ System for quality control workflows in cell and gene therapy development and other biopharma applications. The kits include assays for mycoplasma detection, empty‑full capsid analysis, replication‑competent lentivirus, CHO residual DNA, and E. coli residual DNA. Designed for validated workflows, ready-to-use kits leverage the QX700 platform’s seven‑color multiplexing, streamlined software, and scalable throughput to support sensitive DNA detection and quantification across critical QC processes.
